@MarketMatrixs The short-term outlook is indeed weak, with $92.50 serving as a critical dividing line. However, unless there is a breakdown on high volume, this looks more like a "pause" than an "end."
@StockSavvyShay The stock price is under short-term pressure, but the core business logic and the AI growth narrative remain intact. The decline reflects a market reaction to financing activities rather than a collapse in demand
$CAVA perfectly illustrates why I watch the Recent Lows VWAP closely. Dip buyers consistently showed up right at this level: Feb '26 near $58 Jun '26 near $70 Even when traditional moving averages failed to provide support, the Recent Lows VWAP held strong
$HOOD First target has been reached — strong move
Notably, this strength is coming in despite a generally bearish market backdrop, suggesting buyers are still firmly in control here
@chad_ventures I believe the backtesting of the support area for $NVDA is sound, with a clear buying opportunity. There is potential for a short-term rebound, but it is not advisable to chase the price up
@wave3trades $ONDS is in a healthy pullback (wave 2), with next bullish target at $10.16 (50 DMA), and today’s LADOS launch—an autonomous defense layer powered by Palantir AI—adds a strong fundamental catalyst
@wave3trades $OSCR +100% in 2 months—a textbook breakout! $43 is the next target, with support levels in mind. Optical/AI stocks can move fast once buyers jump in
$OPEN Weekly Bollinger Bands tight and squeezing—big move ahead?
Support held at the lower band. Break $4.90 (20-week SMA + long shelf) → potential upside breakout
@chad_ventures A truly strong trend is not one that rises continuously; rather, it is one that attracts buying support after pulling back to a key support level and then resumes its upward movement
@pdicarlotrader Buying interest strengthened following the liquidity flush, indicating that the bulls still control the short-term momentum; however, further market confirmation is needed to determine whether the rebound can be sustained
@wave3trades In the short term, performance may be weighed down by technical levels and market sentiment; however, provided the fundamentals and industry logic remain unchanged, a pullback represents an opportunity rather than a reversal of the trend
@Fibonacci_TA The price is currently testing the long-term supply-demand dividing line; a path toward 40 exists, but it only becomes truly valid after a structural breakout at 25 is confirmed by a retest
$HIMS successfully held its 50-day moving average📈
A clean move above $32 could open the door to a run toward $40+ without much resistance.
With next month's FDA peptides meeting approaching, the setup continues to look extremely attractive 👀
BULLISH on $HIMS 🚀
$IREN Update: Analysts have set an average price target of $82, with the low at $46. Most forecasts cluster around $90-$100, and I see the stock hitting that range soon! 🚀📈
$HTLM
In the short term, the stock has entered an aggressive upward phase; the initial target range is 2.35–2.45. If trading volume continues to surge, hitting 2.50 or higher is certainly possible!